SOAT1 and prostate carcinoma: In cancer, JAK signaling plays a dual role, as exacerbated signaling is typical of certain types of leukemia, while many solid tumors, including prostate cancer (PCa), are characterized by defects in interferon-induced JAK/STAT signaling.